PHASE-II CLINICAL-STUDY OF CIS-DICHLORODIAMMINEPLATINUM (CDDP) AND VP-16-213 (VP16) IN COMBINATION FOR PATIENTS (PTS) WITH EXTENSIVE NON-SMALL CELL LUNG-CANCER (E-NSCLC)

被引：0
|
作者：
DHINGRA, HM [1 ]
VALDIVIESO, M [1 ]
UMSAWASDI, T [1 ]
SPITZER, G [1 ]
MURPHY, WK [1 ]
CHIUTEN, DF [1 ]
BOOSER, DJ [1 ]
MOUNTAIN, CF [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1981年 / 22卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：200 / 200
页数：1
相关论文
共 50 条
  • [31] CARBOPLATIN (CBDCA, JM-8) AND VP-16-213 IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL-CELL LUNG-CANCER
    BISHOP, JF
    RAGHAVAN, D
    STUARTHARRIS, R
    MORSTYN, G
    ARONEY, R
    KEFFORD, R
    YUEN, K
    LEE, J
    GIANOUTSOS, P
    OLVER, IN
    ZALCBERG, J
    BALL, D
    BULL, C
    FOX, R
    JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (10) : 1574 - 1578
  • [32] PHASE-II EVALUATION OF VP-16-213 IN PATIENTS WITH ADVANCED BREAST-CANCER - A SOUTHWEST-ONCOLOGY-GROUP STUDY
    VAUGHN, CB
    PANETTIERE, F
    THIGPEN, T
    BOTTOMLEY, R
    HOOGSTRATEN, B
    SAMAL, B
    CANCER TREATMENT REPORTS, 1981, 65 (5-6): : 443 - 445
  • [33] RANDOMIZED STUDY OF CYCLOPHOSPHAMIDE, DOXORUBICIN, AND ETOPOSIDE (VP16-213) WITH OR WITHOUT CISPLATINUM IN NON-SMALL CELL LUNG-CANCER
    FUKS, JZ
    AISNER, J
    VANECHO, DA
    SCHIPPER, H
    LEVITT, M
    OSTROW, S
    WIERNIK, PH
    JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (05) : 295 - 301
  • [34] RANDOMIZED TRIAL OF 3 COMBINATIONS OF CISPLATIN WITH VINDESINE AND OR VP-16-213 IN THE TREATMENT OF ADVANCED NON SMALL-CELL LUNG-CANCER
    DHINGRA, HM
    VALDIVIESO, M
    CARR, DT
    CHIUTEN, DF
    FARHA, P
    MURPHY, WK
    SPITZER, G
    UMSAWASDI, T
    JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (02) : 176 - 183
  • [35] CISPLATIN AND ETOPOSIDE (VP-16) AS A SINGLE REGIMEN FOR SMALL CELL LUNG-CANCER - A PHASE-II TRIAL
    BONI, C
    COCCONI, G
    BISAGNI, G
    CECI, G
    PERACCHIA, G
    CANCER, 1989, 63 (04) : 638 - 642
  • [36] PHASE-II TRIAL OF CISPLATIN AND VP-16 IN PREVIOUSLY TREATED SMALL CELL LUNG-CANCER (SCLC)
    BATIST, G
    IHDE, DC
    COWAN, K
    VEACH, S
    GILLIOM, M
    BUNN, PA
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1984, 25 (MAR): : 175 - 175
  • [37] PHASE-II STUDY OF CIS-DIAMMINEDICHLOROPLATINUM IN PATIENTS WITH NON-SMALL CELL LUNG-CANCER
    FUJITA, J
    SAIJO, N
    EGUCHI, K
    SHIMIZU, E
    SHINKAI, T
    TOMINAGA, K
    SASAKI, Y
    FUTAMI, H
    SAKURAI, M
    HOSHI, A
    JAPANESE JOURNAL OF CANCER RESEARCH, 1985, 76 (05): : 420 - 423
  • [38] VINDESINE (DVA) AND CIS-DICHLORODIAMMINEPLATINUM-II (DDP) COMBINATION CHEMOTHERAPY IN NON-SMALL CELL LUNG-CANCER (NSCLC)
    CASPER, ES
    GRALLA, RJ
    GOLBEY, RB
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 337 - 337
  • [39] TREATMENT OF REFRACTORY ACUTE MYELOID-LEUKEMIA WITH MAMSA AND VP-16-213 IN COMBINATION - RESULTS OF A CLINICAL PHASE-I PHASE-II STUDY
    HIDDEMANN, W
    URBANITZ, D
    PREUSSER, P
    ACHTERRATH, W
    BUCHNER, T
    HEMATOLOGICAL ONCOLOGY, 1989, 7 (04) : 267 - 273
  • [40] PHASE-II STUDY OF SPIROGERMANIUM IN ADVANCED (EXTENSIVE) NON-SMALL CELL LUNG-CANCER
    DHINGRA, HM
    UMSAWASDI, T
    CHIUTEN, DF
    MURPHY, WK
    HOLOYE, PY
    SPITZER, G
    VALDIVIESO, M
    CANCER TREATMENT REPORTS, 1986, 70 (05): : 673 - 674
12345